ALO KG – My take-away from listening to a smattering of ALO CC’s was that the company was claiming docs would gravitate toward any effective painkiller that possessed the Good Housekeeping seal of approval as being (drum roll…) Abuse Resistant! Once any such drug reached the market, docs would all but have to do this to avert malpractice suits.
Or so ALO claimed, unless I misunderstood what they were saying, which is entirely possible.
If morphine and oxycodone are considered wholly non-fungible from a medical standpoint, then KG’s dealmaking indeed makes sense. As you can probably tell, the pain market is one that I do not know especially well.
News 
Market Data 
Discover 
AI
